CDKN2A has been classified as a tumor suppressor, methylation studies have detected promoter hypermethylation of CDKN2A in oral and oropharyngeal cancer tissue as well in OPL; therefore CDKN2A inactivation is in part due to promoter methylation (98–102). Here, CDKN2A is linked to neoplasm.